首页> 外国专利> METHOD FOR PRODUCING RACEMIC OR OPTICALLY-ACTIVE HETEROCYCLIC COMPOUND OR ITS PHARMACEUTICALLY ACCEPTABLE ACID-ADDITIVE SALTS OR PHARMACEUTICALLY ACCEPTABLE CATION SALTS WHEN COMPOUND CONTAINS CARBOXYGROUP

METHOD FOR PRODUCING RACEMIC OR OPTICALLY-ACTIVE HETEROCYCLIC COMPOUND OR ITS PHARMACEUTICALLY ACCEPTABLE ACID-ADDITIVE SALTS OR PHARMACEUTICALLY ACCEPTABLE CATION SALTS WHEN COMPOUND CONTAINS CARBOXYGROUP

机译:当化合物含有羧化物时,生产一种具有旋光性或光学活性的杂环化合物或其药学上可接受的酸添加剂盐或药学上可接受的阳离子盐的方法

摘要

(A) Bicyclic cpds. of formula (I) and their salts are new; where n = 0 or 1; m = 0-3; X = CH2, O, S, SO, SO2, NH or 1-4C alkylimino; X1 = CH2, O, S, SO or SO2; Y+Y1 = O, or Y = H and Y1 = OH or in-vivo hydrolysable acyloxy; Z = CH2, CHMe, CH2CH2 or CH2CH2CH2; Z1 = CH or N; R = 2-, 3- or 4-pyridyl, 2-, 3-, 4- or 8-quinolyl, 1-, 3- or 4-isoquinolyl, etc , , all opt. mono- or disubstd. R1 = a C-bonded phenyl, naphthyl, pyridyl, quinolyl, isoquinolyl, pyridazinyl, cinnolinyl, phthalazinyl, pyrimidinyl, naphthyridinyl, pyrrolyl, N-R11-pyrrolyl,, indolyl, N-R11-indolyl, isoindolyl, N-R11-isoindolyl, indolizinyl, pyrazolyl, 1-R11-pyrazolyl, indazolyl, 1-R11-1H-indazolyl, 2-R11-2H-indazolyl, imidazolyl, 1-R11-imidazolyl, benzimidazolyl, 1-R11-benzimidazolyl, furyl, benzofuranyl, isobenzofuranyl, oxazolyl, benzoxazolyl, isoxazolyl, benzo(c)isoxazolyl, benzo(d)isoxazolyl, thienyl, benzothiophenyl, isobenzothienyl, thiazolyl, benzothiazolyl, isothiazolyl, benzo(c)isothiazolyl or benzo(d)isothiazolyl gp., or may be 1-pyrrolyl, 1-indolyl, 2-isoindolyl, 1-pyrazolyl, 1(1H)-indozolyl, 2(2H)-indazolyl, 1-imidazolyl or 1-benzimidazolyl when X1 = CH2 or m is at least 2, where R1 is opt. mono- or disubstd. R1 and R11 = 1-4C alkyl. (B) Intermediates of formula (II) and (III) are also new: where Y2 + Y3 = O, or Y2=H and Y3 = OH; Ra = OH or benzyloxy; Rb+Rc = hydroxymethylene or diazo, or Rb = H and Rc = Br; Rb = phenyl or R.
机译:(A)双环cpds。式(I)的化合物及其盐是新的;其中n = 0或1; m = 0-3; X = CH2,O,S,SO,SO2,NH或1-4C烷基亚氨基; X1 = CH2,O,S,SO或SO2; Y + Y1 = O,或Y = H且Y1 = OH或体内可水解的酰氧基; Z = CH2,CHMe,CH2CH2或CH2CH2CH2; Z1 = CH或N; R = 2-,3-或4-吡啶基,2-,3-,4-或8-喹啉基,1-,3-或4-异喹啉基等,全部选择。单或怀疑。 R1 = C键合的苯基,萘基,吡啶基,喹啉基,异喹啉基,哒嗪基,肉桂基,邻苯二甲酰基,嘧啶基,萘啶基,吡咯基,N-R11-吡咯基,吲哚基,N-R11-吲哚基,异吲哚基,N-R11 ,吲哚嗪基,吡唑基,1-R11-吡唑基,吲唑基,1-R11-1H-吲唑基,2-R11-2H-吲唑基,咪唑基,1-R11-咪唑基,苯并咪唑基,1-R11-苯并咪唑基,呋喃基,苯并呋喃基,异苯并呋喃基,恶唑基,苯并恶唑基,异恶唑基,苯并(c)异恶唑基,苯并(d)异恶唑基,噻吩基,苯并噻吩基,异苯并噻吩基,噻唑基,苯并噻唑基,异噻唑基,苯并(c)异噻唑基或1-苯并[g]异噻唑基。当X1 = CH2或m至少为2时,吡咯基,1-吲哚基,2-异吲哚基,1-吡唑基,1(1H)-吲唑基,2(2H)-吲唑基,1-咪唑基或1-苯并咪唑基,其中R1为opt 。单或怀疑。 R1和R11 = 1-4C烷基。 (B)式(II)和(III)的中间体也是新的:其中Y 2 + Y 3 = O,或Y 2 = H且Y 3 = OH; Ra = OH或苄氧基; Rb + Rc =羟甲基或重氮,或Rb = H且Rc = Br; Rb =苯基或R。

著录项

  • 公开/公告号RU1780537C

    专利类型

  • 公开/公告日1992-12-07

    原文格式PDF

  • 申请/专利权人 PFIZER;

    申请/专利号SU19884356748

  • 申请日1988-10-18

  • 分类号C07C49/83;A61K31/00;A61K31/045;A61K31/085;A61K31/35;A61K31/352;A61K31/353;A61K31/38;A61K31/382;A61K31/40;A61K31/425;A61K31/44;A61K31/4427;A61K31/443;A61K31/4433;A61K31/47;A61K31/50;A61P3/00;A61P9/08;A61P9/10;A61P11/00;A61P11/06;A61P19/02;A61P29/00;C07C43/253;C07C45/00;C07C45/62;C07C45/63;C07C45/67;C07C45/68;C07C45/71;C07C45/74;C07C49/747;C07C49/755;C07C67/00;C07D213/28;C07D213/30;C07D215/14;C07D215/20;C07D215/22;C07D215/233;C07D215/36;C07D215/38;C07D277/64;C07D311/22;C07D313/08;C07D313/12;C07D335/02;C07D335/06;C07D401/06;C07D401/12;C07D401/14;C07D403/06;C07D405/04;C07D405/06;C07D405/12;C07D405/14;C07D407/04;C07D407/06;C07D409/12;C07D417/06;C07D417/12;C07D417/14;C07D419/12;C07D515/04;C12N9/99;

  • 国家 RU

  • 入库时间 2022-08-22 05:04:19

相似文献

  • 专利
  • 外文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号